1. Home
  2. UNF vs VRDN Comparison

UNF vs VRDN Comparison

Compare UNF & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unifirst Corporation

UNF

Unifirst Corporation

HOLD

Current Price

$259.42

Market Cap

4.2B

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$28.38

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNF
VRDN
Founded
1936
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
2.7B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
UNF
VRDN
Price
$259.42
$28.38
Analyst Decision
Sell
Strong Buy
Analyst Count
4
13
Target Price
$180.75
$41.17
AVG Volume (30 Days)
186.0K
1.1M
Earning Date
04-09-2026
05-25-2026
Dividend Yield
0.56%
N/A
EPS Growth
2.70
N/A
EPS
1.89
N/A
Revenue
$1,696,489,000.00
$5,706,000.00
Revenue This Year
$3.40
$13.90
Revenue Next Year
$3.54
$284.55
P/E Ratio
$139.78
N/A
Revenue Growth
6.63
N/A
52 Week Low
$147.66
$9.90
52 Week High
$271.35
$34.29

Technical Indicators

Market Signals
Indicator
UNF
VRDN
Relative Strength Index (RSI) 73.72 42.79
Support Level $166.39 $26.31
Resistance Level N/A $33.71
Average True Range (ATR) 7.72 1.58
MACD 1.39 0.12
Stochastic Oscillator 71.22 46.21

Price Performance

Historical Comparison
UNF
VRDN

About UNF Unifirst Corporation

UniFirst Corp provides uniform and workwear programs, facility management, and safety supplies and services across North America. It designs, manufactures, rents, cleans, and sells uniforms and protective clothing, including flame-resistant and high-visibility garments. It also offers industrial wiping products, floor mats, cleaning supplies, first aid cabinets, and fire protection services such as inspection and maintenance. Serving various industries, the company provides customized uniforms and specialized cleaning for nuclear and cleanroom facilities. It operates through three segments: Uniform & Facility Service Solutions, First Aid & Safety Solutions, and Other, with the majority of revenue from Uniform & Facility Service Solutions.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: